Xenetic Biosciences (XBIO) Stock Price, Quote, News & History | Benzinga

Xenetic Biosciences Inc (XBIO) Stock Price, Quote, News & History

XBIONASDAQ

Trade with Public

Trade with Public

$3.13

-0.01-0.32%

At close: Apr 23, 5:00 PM EST

$3.20

0.072.24%

After Hours: 9:25 AM EST

OverviewNews Earnings Analyst Ratings Short Interest Stock Report

Key Statistics

Open

$3.27

Close

$3.13

Volume / Avg.

16.78K / 23.34K

Day Range

$3.02 - $3.27

52 Wk Range

1.90 - 13.93

Market Cap

$7.33M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

52

Short Interest

0.93%

Days to Cover

1

Recent Xenetic Biosciences Inc News

Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges

Benzinga Edge Stock Rankings evaluate companies across four key factors. Here are three big companies that stood out this week.

Henry Khederian

4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings

Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam as the market rally broadens and major indexes continue to reach new highs. Here's a look at four stocks flashing strong momentum signals.

Dylan Berman

Lack Of Catalysts Prompts Analyst To Downgrade Xenetic Biosciences

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-2.29M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

4.00M

Free Cash Flow (TTM)

-2.29M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

1.72M

Valuation Metrics

Enterprise Value

-$688.26K

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.80

PB Ratio (TTM)

0.97

Earnings Yield % (TTM)

-50.32%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.23

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$7.88M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$3.27

Close

$3.13

Volume / Avg.

16.78K / 23.34K

Day Range

$3.02 - $3.27

52 Wk Range

1.90 - 13.93

Market Cap

$7.33M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

52

Short Interest

0.93%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunothe...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Xenetic Biosciences (XBIO) stock?

A

You can purchase shares of Xenetic Biosciences (NASDAQ:XBIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Xenetic Biosciences (XBIO) competitors?

A

Other companies in Xenetic Biosciences’s space includes: Ernexa Therapeutics Inc (NASDAQ:ERNA), Immuron Ltd (NASDAQ:IMRN), Acurx Pharmaceuticals Inc (NASDAQ:ACXP), Alpha Compute Corp (NASDAQ:ALP) and Can Fite Biopharma Ltd (AMEX:CANF).

Q

What is the forecast, or price target, for Xenetic Biosciences (XBIO) stock?

A

There is no analysis for Xenetic Biosciences to provide a consensus price target.

Q

What is the current price for Xenetic Biosciences (XBIO)?

A

The stock price for Xenetic Biosciences (NASDAQ: XBIO) is $3.2 last updated April 23, 2026 at 9:25 AM EDT.

Q

Does Xenetic Biosciences (XBIO) pay a dividend?

A

There are no upcoming dividends for Xenetic Biosciences.

Q

When is Xenetic Biosciences (NASDAQ:XBIO) reporting earnings?

A

Xenetic Biosciences does not have any upcoming earnings scheduled.

Q

Is Xenetic Biosciences (XBIO) going to split?

A

There is no upcoming split for Xenetic Biosciences.

Q

What sector and industry does Xenetic Biosciences (XBIO) operate in?

A

Xenetic Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Ernexa Therapeutics Inc

Acurx Pharmaceuticals Inc

Alpha Compute Corp

Can Fite Biopharma Ltd

BioRestorative Therapies Inc

TransCode Therapeutics Inc

Indaptus Therapeutics Inc